Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

AMRI Appoints Paul Feuerman as Senior Vice President, General Counsel and Head of Business Development

AMRI
Posted on: 30 Oct 17

ALBANY, N.Y., Oct. 30, 2017 /PRNewswire/ -- AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life, today announced that Paul Feuerman has joined the company as senior vice president, general counsel and head of business development. Mr. Feuerman will be responsible for leading all AMRI's legal, M&A, and corporate affairs activities for the company's locations worldwide. Lori M. Henderson will transition from AMRI in the coming months to pursue new opportunities.

"Paul brings a breadth of knowledge to AMRI having served as general counsel to both public and privately held companies in the specialty pharmaceutical, generics, and clinical development sectors of the industry," said William S. Marth, president and chief executive officer, AMRI. "He has substantial M&A transaction expertise including experience with international transactions, business line extensions, public securities and debt offerings. This experience will be critical to us as we continue to look to grow our business. I would like to express my sincere gratitude to Lori for her significant and valuable contributions to AMRI during the past seven years. We wish her success with her future endeavors."

Previously, Mr. Feuerman was assistant general counsel, global business development at Mylan, where he provided counsel in support of several business transactions including, but not limited to, the $1.6 billion acquisition of Agila global injectables and oncolytics businesses; the $5.3 billion acquisition of Abbott's non-U.S. developed markets specialty and branded generics business; and HSR divestitures in support of the $7.2 billion acquisition of Meda. Prior to this, he served as General Counsel for SciDose LLC. Earlier in his career, he served as general counsel at Axonyx Inc. and executive vice president and general counsel at Schein Pharmaceutical Inc.

Mr. Feuerman holds a bachelor's degree from Trinity College, Hartford, Conn., and earned a Juris Doctor degree from Columbia Law School, New York, N.Y.

About AMRI
AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI's team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical and Solid State Services, API Manufacturing and Drug Product. For more information about AMRI, visit www.amriglobal.com.

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 30/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.